DJIA 18,162.99 121.45 0.67%
NASDAQ 5,106.59 73.84 1.47%
S&P 500 2,123.48 19.28 0.92%
market minute promo


company name or ticker

Synageva BioPharma Files for Kanuma's Approval in Japan - Analyst Blog

New Strong Sell Stocks for May 26th - Tale of the Tape

'Fast Money' Recap: This Stock Has Risen Every Summer for the Past Decade

Why I Bought The Dips In Both Gilead And Achillion Today

Why I'm Buying Sarepta Therapeutics Stock

Sarepta Therapeutics got some great news from the FDA yesterday that sent shares soaring. Here's why the stock is definitely worth a deeper dive by risk-tolerant investors.

Consolidation Is Good - Cramer's Mad Money (5/18/15)

Biotech Stock Roundup: Alexion to Buy Synageva, FDA Panel Backs Vertex's Orkambi - Analyst Blog

Short Sellers Start to Get Nervous on Biotech

ETFs in Focus on Impressive Q1 Biotech Earnings - ETF News And Commentary

ETFs in Focus on Impressive Q1 Biotech Earnings - ETF News And Commentary

Oppenheimer Downgrades Dyax

See More Articles...